Rare diseases
Investigational molecules
Locations
Study on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis
GermanyLong-term study of upadacitinib tablets for adults with Crohn's disease
DenmarkStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
BelgiumStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
AustriaStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
AustriaStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
BelgiumStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
AustriaStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
BelgiumStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
AustriaStudy on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis
AustriaStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
